Johnson & Johnson

News

NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market.

News

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

Oncology

In conversation with Johnson & Johnson experts at ESMO 2025, discussing T-cell-redirecting bispecific antibodies and the future of immunotherapy.

News

Thousands of people in the UK have joined a lawsuit against Johnson & Johnson, claiming that it knowingly sold talc products that caused cancer.

News

Johnson & Johnson has said it wants to spin off its orthopaedics division as part of an effort to redirect its business towards higher-growth areas.

News

Johnson & Johnson has suffered a setback in its long-running legal defence against claims its talc products cause cancer.